U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT07559682) titled 'Efficacy of Selective COX-2 Inhibitors in Relieving Orthodontic Pain' on April 14.

Brief Summary: The purpose of this study is to compare the efficacy of selective COX-2 inhibitors{ etoricoxib vs celecoxib )in relieving orthodontic pain , after initial bonding and arch wire insertion.

Study Start Date: May 08, 2025

Study Type: INTERVENTIONAL

Condition: Orthodontic Pain (D013850)

Intervention: DRUG: Celecoxib

Group A will be given Celecoxib 50mg once a day.

DRUG: Etoricoxib (Treatment Group)

Group B will be given Etoricoxib 60mg once a day.

Recruitment Status: ACTIVE_NOT_RECRUITING

Sponsor: Sharif Medical Research Center

Di...